Veit Rothhammer

Veit received an MD degree from the University of Wuerzburg in Germany and was board certified in Neurology at the Technical University in Munich in 2013. Being a member of the research groups of Prof. Dr. Thomas Korn and Prof. Dr. Bernhard Hemmer, his research focused on the migration of T cells in autoimmune and pathogen mediated diseases of the CNS. He moved to Francisco Quintana’s lab at Harvard Medical School in 2014, where he studied the role of astrocytes in the context of CNS inflammation. In 2018, he moved back to Germany to become Attending Neurologist at the Department of Neurology at the Technical University Munich (Prof. Dr. B. Hemmer), where he established his independent research group supported by a Heisenberg fellowship (German research foundation, DFG) to study glial co-inhibitory signaling. He was awarded an ERC Starting grant in 2020 to investigate reparative glial mediators in tissue regeneration in MS and preclinical animal models. In 2020, he accepted an appointment as Full Professor of Neuroimmunology (W3) at the Department of Neurology (Chair Prof. Dr. Dr. Schwab) at Friedrich Alexander University Erlangen.
His main research focus is the role of glial cells such as astrocytes and microglia in acute and chronic autoimmune inflammatory tissue damage with the goal of developing novel therapeutic strategies for hence untreatable stages of MS and potentially other neurodegenerative diseases.

 
 

Anne Peter

Anne received her bachelor’s degree in Molecular Medicine at the Friedrich-Alexander-University Erlangen-Nürnberg, where she worked in the laboratory of Stephan von Hörsten on the characterization of a preclinical animal model of Parkinson´s disease. During the time of her master´s program in Molecular Medicine, she performed an internship in the group of Åsa Petersén at the Translational Neuroendocrine Research Unit, Lund University (Sweden) focusing on the hypothalamic pathology in Huntington’s disease. Anne accomplished her master´s thesis in the group of Ruth Beckervordersandforth at the Institute of Biochemistry working on the regulation of neuronal and astrocytic fate decisions in the adult hippocampus. Since February 2022, Anne is a PhD student in the Rothhammer lab to investigate inflammation-modulating factors governed by glial cells and their impact on autoimmune CNS inflammation.

 
 
Bild1.jpg

Oliver VANDREY

Oliver obtained his bachelor’s degree in applied chemistry with the focus on biochemistry at the Nuremberg Institute of Technology and the Friedrich-Alexander University Erlangen, where he worked in the group of Wei Xiang on the aggregation behaviour of α-synuclein in dopaminergic neurons in Parkinson’s disease. He continued his education at the Nuremberg Institute of Technology and completed his master’s thesis at the Technical-University Munich by working in the group of Selina Keppler at the TranslaTUM on the role of the actin cytoskeleton in dendritic cell function and the regulation of Dectin-1 signalling. Afterwards he joined the R&D department of infectious diseases at Roche Diagnostics in Penzberg, to broaden his scientific knowledge in the field of industrial research. In June 2021, Oliver joined the Rothhammer lab to return to his scientific roots and work on epigenetic changes in the context of autoimmune neuroinflammation.

 
 

Julia Zissler

Julia obtained her bachelor's degree at the University of Regensburg in Prof. Seufert's research group, where she characterised phenotypic and metabolic changes of protein biosynthesis mutants in yeast. She continued her education as part of the elite master's programme in Integrated Immunology at the Friedrich-Alexander-University, and deepened her expertise during a stay abroad in the laboratory of Dr.
Weichhart at the Medical University of Vienna, working on the metabolic profile of resident tissue macrophages. Julia joined the Rothhammer Lab April 2023 for her master's thesis focusing on gene expression of astrocytes in the context of an altered micriobiome.  Graduating as valedictorian, she subsequently started her PhD and started focussing on astrocytic extracellular vesicles and their variations.

 
 

Vivienne Riekher

Vivienne is a PhD student at the Rothhammer lab who received her Bachelor's degree in Biology at the Institute of Microbiology, Infection and Hygiene at the Friedrich-Alexander-University Erlangen-Nuremberg in the research group of Prof. Dr. Jochen Mattner, where she investigated the role of L-arginine metabolism in the pathogenesis of Salmonella Typhimurium. She continued her studies in the Integrated Immunology Master's Program of the Elite Network Bavaria, during which she carried out an internship in the Ashouri-Sinha laboratory at the University of California San Francisco (UCSF) in California (USA). There, she researched the expression of co-stimulatory receptors on T cells in different mouse models of rheumatoid arthritis. She completed her Master’s with her thesis on the influence of CD83 on microglia in neuroinflammation and neurodegeneration at the Department of Immunomodulation in the laboratory of Prof. Dr. Alexander Steinkasserer. Since December 2024, Vivienne is studying the function of leukemia inhibitory factor (Lif) and its receptor in glia cells and the role of long-lived RNAs in different experimental settings.

 
 

Leander Ammon

Leander began his medical studies at Friedrich-Alexander-University Erlangen-Nürnberg in the spring of 2021, after completing his radiographer training and working at Freiburg University Hospital for several years. In March 2024, Leander joined the MD-thesis graduate program at the Interdisciplinary Center for Clinical Research Erlangen (ICCF) and became a member of the Rothhammer Lab. His research focuses on developing new biomarkers for monitoring the progression and treatment of autoimmune and inflammatory diseases, particularly neuromyelitis optica spectrum disorders.

 
 

Eva Zachmeier

Eva began her medical studies at Friedrich-Alexander-University Erlangen-Nürnberg in spring 2020 after a voluntary practical year at Erlangen University Hospital. In April 2024, Eva joined the Rothhammer Lab for her dissertation thesis. Her research focuses on investigating the effects mediated by pro-inflammatory cytokines on the blood-brain-barrier in inflammatory CNS-disease.

 
 

Finnja Zuber

Finnja started studying the Bachelor’s program in Molecular Medicine and Medicine at the Friedrich-Alexander-University Erlangen-Nürnberg after completing a voluntary scientific year at the Carl-von-Ossietzky-University Oldenburg. Since 2022, Finnja has worked as a student assistant in the Rothhammer Lab and is now pursuing her Bachelor’s thesis in the lab focusing on microglial crosstalk and novel therapeutic strategies for autoimmune CNS diseases.

 
 
thanos.png

Thanos Tsaktanis

Thanos studied medicine at the Ludwig Maximilian University of Munich and started his residency in 2017 at the Department of Neurology at the Technical University Munich. In 2018, he completed his MD thesis and joined in the same year the Rothhammer lab as a clinician scientist. He is currently investigating the therapeutic effect of protective glial mediators on different stages of autoimmune CNS inflammation and tries to identify biomarkers for monitoring the course and therapy of multiple sclerosis. In September 2020, Thanos moved together with the lab to its new location in Erlangen.

 
 

Justus Hercher

After achieving his A-Levels in Nuremberg in 2017 and completing internships in the medical field, Justus began his study of medicine at the Charles University of Prague in Pilsen. After receiving the offer from University of Erlangen-Nürnberg Justus continued his academic pursuits and completed his M1 governmental exam in 2021 at the University of Erlangen-Nürnberg, where he is currently studying. Justus gained practical experience in the medical field through his internships at Klinikum Nürnberg Nord and Dr. Erler Klinik, both in Nuremberg, where he worked in orthopedics. During the COVID-19 crisis, he also assisted with crisis management in healthcare at the Nuremberg health department. Justus continued his involvement in healthcare by joining the Microbiological Institute of University Hospital Erlangen, where he served as a SARS-CoV-2 Specialist Information Service for Hospital Staff. He is currently working at the Institute of Experimental and Clinical Pharmacology and Toxicology of University Erlangen. In 2023, he joined the lab of Prof. Rothhammer for his dissertation thesis. The research is focused to investigate the protective effects mediated by hypoxia on glia in inflammatory CNS-disease.

 
 

Ulrike Naumann

Ulrike finished her education as a biological-technical assistant in 2002 and has since then worked as a technician in different research labs in Erlangen. She now joined the Rothhammer lab in September 2020 and brings in her broad expertise in different techniques.

 
 

Karl Ama

Karl is a guest researcher from Tibet, working on the impact of saliva on neuroinflammation. He obtained his PhD at the University of Applied Sciences in Tibet. In his recent publication, which appeared in the Journal of Lamoids, he describes the role of Cameloids as producers of antibodies.


 

Alumni


Dr. Mathias Linnerbauer

Dr. Lena Lößlein

Ana Cirac

Tobias Beyer

Lucy Nirschl

Alexander Beer

Nora Schwingen

Emely Neumaier

Alicia Martinek